Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M I Mackness

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Atherosclerosis|July 25, 1998
Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemiaP N Durrington, M I Mackness, D Bhatnagar, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 8, 2001
Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokinesC H Bolton, L G Downs, J G Victory, et al.
European Journal of Clinical Investigation|December 15, 2000
Apolipoproteins A-I, A-II and B, lipoprotein(a) and the risk of ischaemic heart disease: the Caerphilly studyP M Sweetnam, C H Bolton, L G Downs, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 15, 2001
Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?B Mackness, G K Davies, W Turkie, et al.
Current Opinion in Lipidology|September 18, 1998
Paraoxonase and coronary heart diseaseM I Mackness, B Mackness, P N Durrington, et al.
Atherosclerosis|August 26, 1998
Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitusB Mackness, M I Mackness, S Arrol, et al.
Clinical Science (London, England : 1979)|July 1, 1993
Relationship between serum butyrylcholinesterase activity, hypertriglyceridaemia and insulin sensitivity in diabetes mellitusC A Abbott, M I Mackness, S Kumar, et al.
Atherosclerosis|July 12, 2005
Impact of migration on coronary heart disease risk factors: comparison of Gujaratis in Britain and their contemporaries in villages of origin in IndiaJ V Patel, A Vyas, J K Cruickshank, et al.
Lancet (London, England)|February 18, 1995
Coronary risk factors in people from the Indian subcontinent living in west London and their siblings in IndiaD Bhatnagar, I S Anand, P N Durrington, et al.
Nephron|January 1, 1997
Influence of immunosuppressive therapy on lipoprotein(a) and other lipoproteins following renal transplantationJ H Brown, B G Murphy, A F Douglas, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Atherosclerosis|July 25, 1998
Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemiaP N Durrington, M I Mackness, D Bhatnagar, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 8, 2001
Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokinesC H Bolton, L G Downs, J G Victory, et al.
European Journal of Clinical Investigation|December 15, 2000
Apolipoproteins A-I, A-II and B, lipoprotein(a) and the risk of ischaemic heart disease: the Caerphilly studyP M Sweetnam, C H Bolton, L G Downs, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 15, 2001
Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?B Mackness, G K Davies, W Turkie, et al.
Current Opinion in Lipidology|September 18, 1998
Paraoxonase and coronary heart diseaseM I Mackness, B Mackness, P N Durrington, et al.
Atherosclerosis|August 26, 1998
Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitusB Mackness, M I Mackness, S Arrol, et al.
Clinical Science (London, England : 1979)|July 1, 1993
Relationship between serum butyrylcholinesterase activity, hypertriglyceridaemia and insulin sensitivity in diabetes mellitusC A Abbott, M I Mackness, S Kumar, et al.
Atherosclerosis|July 12, 2005
Impact of migration on coronary heart disease risk factors: comparison of Gujaratis in Britain and their contemporaries in villages of origin in IndiaJ V Patel, A Vyas, J K Cruickshank, et al.
Lancet (London, England)|February 18, 1995
Coronary risk factors in people from the Indian subcontinent living in west London and their siblings in IndiaD Bhatnagar, I S Anand, P N Durrington, et al.
Nephron|January 1, 1997
Influence of immunosuppressive therapy on lipoprotein(a) and other lipoproteins following renal transplantationJ H Brown, B G Murphy, A F Douglas, et al.
Pageof 10